Renovaro Biosciences
RENB
#8802
Rank
โ‚ฌ92.24 M
Marketcap
0,57ย โ‚ฌ
Share price
-4.43%
Change (1 day)
-80.50%
Change (1 year)

Earnings for Renovaro Biosciences (RENB)

Earnings in 2024 (TTM): -โ‚ฌ0.11 Billion

According to Renovaro Biosciences's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -โ‚ฌ39.07 Million, an increase over its 2022 earnings that were of -โ‚ฌ0.11 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Renovaro Biosciences from 2012 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -โ‚ฌ0.11 Billion173.27%
2023 -โ‚ฌ39.07 Million-62.03%
2022 -โ‚ฌ0.11 Billion182.88%
2021 -โ‚ฌ36.38 Million246.9%
2020 -โ‚ฌ10.49 Million614.13%
2019 -โ‚ฌ1.47 Million-93.65%
2018 -โ‚ฌ23.13 Million1119.78%
2017 -โ‚ฌ1.9 Million-29.21%
2016 -โ‚ฌ2.68 Million
2014 -โ‚ฌ2.43 Million6701.79%
2013 -โ‚ฌ0.04 Million16.61%
2012 -โ‚ฌ0.04 Million